Nurse Emran Mohammad Hit with DEA Decision and Order
Published Date: 9/11/2026
Notice
Summary
No summary available.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
DEA Registration Revoked for Named APRN
The Drug Enforcement Administration revoked DEA Certificate of Registration No. MM8483024 issued to Emran Mohammad, RN, APRN, CNP, and denied any pending application to renew or modify that registration as well as any other pending application for additional registration in Minnesota. The Order is effective October 13, 2026.
State License Suspension Bars DEA Registration
The Order reiterates that under 21 U.S.C. 824(a)(3) and related provisions, a registrant who lacks state authority to handle controlled substances (for example because a state nursing or APRN license is suspended) is not eligible to maintain a DEA registration and that lack of state authority is an independent basis for revocation.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-18604, Joseph John Stubbers III, D.O.; Decision and Order
Dr. Joseph John Stubbers III from Ohio lost his DEA registration to handle controlled substances because he no longer has the legal authority to prescribe them in Ohio. He didn’t ask for a hearing to challenge this, so the DEA officially revoked his registration as of February 28, 2026. This means he can’t legally prescribe or manage controlled drugs anymore, impacting his medical practice and patients.
2026-18597, Craig Cohen, DPM; Decision and Order
2026-18599, Cheryl White, N.P.; Decision and Order
2026-18200, Stephen Bossenberry, M.D.; Decision and Order
Dr. Stephen Bossenberry from Michigan lost his DEA registration because he no longer has the legal right to handle controlled substances in his state. He didn’t ask for a hearing to challenge this, so the DEA officially revoked his registration, which expired on July 31, 2026. This means he can’t prescribe or manage controlled drugs anymore, effective immediately.
Previous / Next Documents
Previous: 2026-18604, Joseph John Stubbers III, D.O.; Decision and Order
Dr. Joseph John Stubbers III from Ohio lost his DEA registration to handle controlled substances because he no longer has the legal authority to prescribe them in Ohio. He didn’t ask for a hearing to challenge this, so the DEA officially revoked his registration as of February 28, 2026. This means he can’t legally prescribe or manage controlled drugs anymore, impacting his medical practice and patients.
Next: 2026-18606, Notice of Availability of Final Environmental Assessment and Finding of No Significant Impact
Pursuant to the provisions of Title 41 of the Fixing America's Surface Transportation Act (FAST-41) (42 United States Code (U.S.C.) 4370m et seq.), The DoD (referred to herein as "the Department of War" or "DoW") announces the availability of the Final Environmental Assessment (EA) and Finding of No Significant Impact (FONSI), following DoW's evaluation of the potential environmental effects of the construction and operation of an integrated non-ferrous smelting and refining facility and associated infrastructure in Montgomery County, Tennessee.